Tumor-specific activation coupled with protection of normal tissues by utilizing tetrahydrouridine in combination with a novel antineoplastic prodrug, 5-trifluoromethyldeoxycytidine: A new concept in chemotherapy

D. A. Boothman, S. Greer

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Tumor-specific activation coupled with protection of normal tissues by utilizing tetrahydrouridine in combination with a novel antineoplastic prodrug, 5-trifluoromethyldeoxycytidine: A new concept in chemotherapy'. Together they form a unique fingerprint.